🔥🐔 BizChicken 🐔🔥

Companies Similar to The Oncology Institute, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Ikena Oncology, Inc.

Ikena Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

IK-930

Ikena Oncology is a targeted oncology company developing medicines tailored to biomarker-defined patient groups, with a focus on unmet needs in cancer treatment.

Tags: biomarkers, biotechnology, cancer treatment, oncology, pharmaceuticals

Symbol: IKNA

Recent Price: $1.60

Industry: Biotechnology

CEO: Dr. Mark Manfredi Ph.D.

Sector: Healthcare

Employees: 18

Address: 645 Summer Street, Boston, MA 02210

Phone: 857 273 8343

Last updated: 2024-12-31

INmune Bio, Inc.

INmune Bio, Inc. logo
Market Cap: Low
Employees: Lowest

INKmune

INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.

Tags: Alzheimer's disease, chronic inflammation, hematologic malignancies, immunotherapy, solid tumors

Symbol: INMB

Recent Price: $4.65

Industry: Biotechnology

CEO: Dr. Raymond Joseph Tesi M.D.

Sector: Healthcare

Employees: 11

Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432

Phone: 858 964 3720

Last updated: 2024-12-31

Option Care Health, Inc.

Option Care Health, Inc. logo
Market Cap: High
Employees: High

Infusion Services

Option Care Health, Inc. provides home and alternate site infusion services across the United States, offering a range of therapies for numerous acute and chronic conditions.

Tags: anti-infective therapies, chronic illness care, home healthcare, immunoglobulin infusion, infusion services, neurological disorders treatment

Symbol: OPCH

Recent Price: $22.66

Industry: Medical - Care Facilities

CEO: Mr. John C. Rademacher

Sector: Healthcare

Employees: 7500

Address: 3000 Lakeside Drive, Bannockburn, IL 60015

Phone: 312 940 2443

Leadership

  • John C. Rademacher, President & Chief Executive Officer
  • Luke Whitworth, Chief Operating Officer
  • Femi Adewunmi, MD, Chief Medical Officer
  • Caroline Budde, SVP, Chief Compliance Officer
  • Chris Grashoff, Chief Growth Officer
  • Mike Shapiro, Chief Financial Officer
  • Jill D. Rhodes, SVP, Chief Information Security Officer
  • Ashley Mikles, SVP, Market Access and Contracting
  • Eric Daugherty, SVP, Biopharma Relations and Programs
  • Mike Bavaro, Chief Human Resources Officer and Chief Diversity Officer
  • Collin Smyser, General Counsel and Corporate Secretary
  • Brett Michalak, Chief Information Officer

Last updated: 2024-12-31

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ORIC-533, ORIC-944, ORIC-114

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.

Tags: ORIC-114, ORIC-533, ORIC-944, biopharmaceutical, cancer treatment, clinical-stage

Symbol: ORIC

Recent Price: $8.17

Industry: Biotechnology

CEO: Dr. Jacob M. Chacko M.B.A., M.D.

Sector: Healthcare

Employees: 107

Address: 240 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 388 5600

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

PYX-106, PYX-102, PYX-201, PYX-202, PYX-203

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.

Tags: antibody drug conjugate, biopharmaceutical, cancer therapy, immune-oncology, solid tumors

Symbol: PYXS

Recent Price: $1.56

Industry: Biotechnology

CEO: Dr. Lara S. Sullivan M.D., MBA

Sector: Healthcare

Employees: 55

Address: 35 Cambridgepark Drive, Cambridge, MA 02140

Phone: 617 221 9059

Last updated: 2024-12-31

Agenus Inc.

Agenus Inc. logo
Market Cap: Low
Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. logo
Market Cap: Low
Employees: Low

ALX148

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.

Tags: CD47, cancer therapy, clinical trials, collaboration, immuno-oncology, solid tumors

Symbol: ALXO

Recent Price: $1.66

Industry: Biotechnology

CEO: Mr. Jason W. Lettmann

Sector: Healthcare

Employees: 81

Address: 323 Allerton Avenue, South San Francisco, CA 94080

Phone: 650 466 7125

Last updated: 2024-12-31

American Oncology Network, Inc.

American Oncology Network, Inc. logo
Market Cap: Lowest
Employees: Medium

Oncology Services

American Oncology Network, Inc. provides comprehensive oncology services, including laboratory, pathology, specialty pharmacy, and care management support services in the United States.

Tags: Care Management, Healthcare, Oncology, Pathology, Patient Support, Specialty Pharmacy

Symbol: AONC

Recent Price: $4.94

Industry: Medical - Care Facilities

CEO: Mr. Todd Schonherz

Sector: Healthcare

Employees: 1525

Address: 14543 Global Parkway, Fort Myers, FL 33913

Phone: 833-886-1725

Last updated: 2024-12-31

Cardiff Oncology, Inc.

Cardiff Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

Onvansertib

Cardiff Oncology, Inc. is a clinical-stage oncology company developing treatment medicine for cancer patients, featuring lead drug candidate onvansertib, targeting various cancers including colorectal cancer. The company is headquartered in San Diego, California.

Tags: biotechnology, cancer treatment, clinical trials, oncology, pharmaceuticals

Symbol: CRDF

Recent Price: $4.26

Industry: Biotechnology

CEO: Dr. Mark Erlander Ph.D.

Sector: Healthcare

Employees: 31

Address: 11055 Flintkote Avenue, San Diego, CA 92121

Phone: 858 952 7570

Last updated: 2024-12-31

Champions Oncology, Inc.

Champions Oncology, Inc. logo
Market Cap: Lowest
Employees: Low

Tumorgraft Technology Platform

Champions Oncology, Inc. specializes in personalized cancer care technology solutions, including the Tumorgraft Technology Platform and Lumin Bioinformatics, aimed at enhancing oncology drug development and usage.

Tags: Bioinformatics, Biotechnology, Cancer Care, Oncology, Personalized Medicine, Pharmaceuticals, Translational Oncology

Symbol: CSBR

Recent Price: $8.62

Industry: Biotechnology

CEO: Dr. Ronnie Morris M.D.

Sector: Healthcare

Employees: 210

Address: One University Plaza, Hackensack, NJ 07601

Phone: 201 808 8400

Last updated: 2024-12-31

Elevation Oncology, Inc.

Elevation Oncology, Inc. logo
Market Cap: Lowest
Employees: Lowest

seribantumab

Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for the treatment of cancer in genomically defined patient populations. Their lead program is seribantumab, an anti-HER3 monoclonal antibody for advanced solid tumors.

Tags: antibody therapy, biopharmaceutical, cancer treatment, genomics, solid tumors, therapeutics

Symbol: ELEV

Recent Price: $0.57

Industry: Biotechnology

CEO: Mr. Joseph J. Ferra Jr.

Sector: Healthcare

Employees: 29

Address: 888 Seventh Avenue, New York, NY 10106

Phone: 716 371 1125

Last updated: 2024-12-31

Immunome, Inc.

Immunome, Inc. logo
Market Cap: Medium
Employees: Low

IMM-ONC-01, IMM-BCP-01

Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.

Tags: antibody therapeutics, biopharmaceutical, infectious disease, oncology

Symbol: IMNM

Recent Price: $10.28

Industry: Biotechnology

CEO: Dr. Clay B. Siegall Ph.D.

Sector: Healthcare

Employees: 78

Address: 665 Stockton Drive, Exton, PA 19341

Phone: 610 321 3700

Last updated: 2024-12-31

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. logo
Market Cap: High
Employees: Medium

lifileucel

Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products to utilize the immune system in eradicating cancer cells, with several ongoing phase 2 clinical studies.

Tags: biotechnology, cancer immunotherapy, cancer treatment, clinical-stage, lifileucel

Symbol: IOVA

Recent Price: $7.17

Industry: Biotechnology

CEO: Dr. Frederick G. Vogt Esq., J.D., Ph.D.

Sector: Healthcare

Employees: 557

Address: 825 Industrial Road, San Carlos, CA 94070

Phone: 650 260 7120

Last updated: 2024-12-31

NeoGenomics, Inc.

NeoGenomics, Inc. logo
Market Cap: High
Employees: High

Cancer-focused testing services

Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.

Tags: cancer testing, cytogenetics, flow cytometry, laboratories, molecular testing, oncology

Symbol: NEO

Recent Price: $16.92

Industry: Medical - Diagnostics & Research

CEO: Mr. Christopher Michael Smith BSc

Sector: Healthcare

Employees: 2100

Address: 9490 NeoGenomics Way, Fort Myers, FL 33912

Phone: 239 768 0600

Leadership

  • Chris Smith, Chief Executive Officer
  • Jeff Sherman, Chief Financial Officer
  • Warren Stone, Chief Commercial Officer
  • Melody Harris, Chief Operations Officer & President, Informatics
  • Ali Olivo, Executive Vice President, General Counsel & Business Development
  • Hutan Hashemi, JD, Chief Compliance Officer
  • Nathan Montgomery, MD, PhD, Vice President, Medical Services
  • Gary Passman, Chief Culture Officer
  • Kareem Saad, Head of Strategy and Transformation
  • Lynn A. Tetrault, Chair of the Board
  • Bruce K. Crowther, Board Member
  • Elizabeth Floegel, Board Member
  • Neil Gunn, Board Member
  • Alison L. Hannah, MD, Board Member
  • Stephen Kanovsky, Board Member
  • Michael A. Kelly, Board Member
  • David Perez, Board Member
  • Tony Zook, Board Member
  • Derek Lyle, MD, Chief Medical Officer
  • Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
  • J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
  • Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
  • Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
  • Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
  • Renuka Agrawal, MD, Senior Hematopathologist
  • Todd S. Barry, MD PhD, Senior Hematopathologist
  • Bora Baysal, MD, PhD, Senior Hematopathologist
  • Saskia Boisot, MD, Senior Hematopathologist
  • Wayne W. Chen, MD PhD, Director of Hematopathology Services
  • Rachel Flamholz, MD, Senior Hematopathologist
  • Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
  • Anselm Hii, MD, Director of Hematopathology Services
  • Thanh Ho, MD, Senior Hematopathologist
  • Kim Janatpour, MD MA, Senior Hematopathologist
  • Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
  • Sameer S. Khatri, MD, Hematopathologist
  • Madeleine Kraus, MD, Senior Hematopathologist
  • Brian Kwok, MD FCAP, Corporate Director of Hematopathology
  • Keming Lin, MD MS FCAP, Senior Hematopathologist
  • Robert Lin, MD, Senior Hematopathologist
  • Russell L. Maiese, M.D., Senior Hematopathologist
  • Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
  • Viera Nelson, MD, Senior Hematopathologist
  • Dennis P. O’Malley, MD, Senior Hematopathologist
  • Anthony Padula, MD, Senior Hematopathologist
  • Munir Shahjahan, MD MPH, Senior Hematopathologist
  • Jesalyn J. Taylor, MD, Senior Hematopathologist
  • Jian-Feng Wang, MD PhD, Senior Hematopathologist
  • Zhao Wu, MD PhD FCAP, Senior Hematopathologist
  • Aine Yung, MD FCAP, Senior Hematopathologist
  • Sadiq Zaman, MD, Senior Hematopathologist
  • Guohua Zhao, MD PhD, Senior Hematopathologist
  • Mitual Amin, MD, Senior Surgical Pathologist
  • Jerry Chu, MD PhD, Senior Surgical Pathologist
  • Ted Farzaneh, MD, Senior Surgical Pathologist
  • Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
  • Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
  • Robert Schwartz, MD, Senior Surgical Pathologist
  • Yae K (Kay) Suh, MD, Senior Surgical Pathologist
  • Matthew Geller, DO, Molecular Pathologist
  • Hao Ho, MD, Molecular Pathologist
  • Jennifer Hummel, MD, Senior Molecular Pathologist
  • Armen Kaysan, MD, Molecular Pathologist
  • Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
  • Saed Sadeghi, MD, Molecular Pathologist
  • Ying Wang, MD PhD, Molecular Pathologist
  • Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
  • Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
  • Indu Gupta, MD, Surgical Pathologist, Pharma Services
  • Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
  • Albert Ho, Director of Pharma Pathology Services
  • Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
  • Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
  • Li Cheng, PhD FACMG, Associate Director of Cytogenetics
  • Liang Dong, MD PhD, Director of Cytogenetic Services
  • Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
  • Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
  • Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
  • John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
  • Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
  • Farzad Nooraie, MD, Director of Cytogenetic Services
  • Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
  • Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
  • Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
  • Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
  • Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
  • Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
  • John N. Allan, MD, Scientific Advisory Board Member
  • Rafael Bejar, MD, PhD, Scientific Advisory Board Member
  • James R. Berenson, MD, Scientific Advisory Board Member
  • Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
  • James Downing, MD, Scientific Advisory Board Member
  • Bernard A Fox, PhD, Scientific Advisory Board Member
  • Gregory Hess, MD, Scientific Advisory Board Member
  • Hatim Husain, MD, Scientific Advisory Board Member
  • Tibor Kovacsovics, MD, Scientific Advisory Board Member
  • Razelle Kurzrock, MD, Scientific Advisory Board Member
  • Gail J. Roboz, MD, Scientific Advisory Board Member
  • Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
  • Mark A. Rubin, MD, Scientific Advisory Board Member

Last updated: 2024-12-31

Predictive Oncology Inc.

Predictive Oncology Inc. logo
Market Cap: Lowest
Employees: Lowest

Personalized Cancer Therapies

Predictive Oncology Inc. is a knowledge-driven company focusing on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States, operating in four segments: Helomics, z PREDICTA, Soluble, and Skyline.

Tags: Artificial Intelligence, Cancer Therapies, Clinical Testing, Disease Models, Drug Discovery, Genomic Profiling, High-Throughput Chromatography

Symbol: POAI

Recent Price: $0.90

Industry: Medical - Instruments & Supplies

CEO: Mr. Raymond F. Vennare

Sector: Healthcare

Employees: 34

Address: 2915 Commers Drive, Eagan, MN 55121

Phone: 651 389 4800

Last updated: 2024-12-31

Instil Bio, Inc.

Instil Bio, Inc. logo
Market Cap: Low
Employees: Lowest

ITIL-168, ITIL-306

Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.

Tags: TIL, biopharmaceutical, cancer therapy, cell therapy, clinical-stage

Symbol: TIL

Recent Price: $18.99

Industry: Biotechnology

CEO: Mr. Bronson Crouch

Sector: Healthcare

Employees: 49

Address: 3963 Maple Avenue, Dallas, TX 75219

Phone: 972 499 3350

Last updated: 2024-12-31

Cullinan Oncology, Inc.

Cullinan Oncology, Inc. logo
Market Cap: Medium
Employees: Low

CLN-081

Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.

Tags: biopharmaceutical, cancer, clinical trials, immuno-oncology, oncology, therapies

Symbol: CGEM

Recent Price: $12.20

Industry: Biotechnology

CEO: Mr. Nadim Ahmed

Sector: Healthcare

Employees: 85

Address: One Main Street, Cambridge, MA 02142

Phone: 617 410 4650

Last updated: 2024-12-31

Immix Biopharma, Inc.

Immix Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMX-110, IMX-111, IMX-120

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.

Tags: Biopharmaceuticals, Clinical Trials, Inflammation, Oncology, Tissue-Specific Therapeutics

Symbol: IMMX

Recent Price: $2.36

Industry: Biotechnology

CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.

Sector: Healthcare

Employees: 14

Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064

Phone: 310 651 8041

Last updated: 2024-12-31

The Oncology Institute, Inc.

The Oncology Institute, Inc. logo
Market Cap: Lowest
Employees: Medium

Medical Oncology Services

An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.

Tags: Cancer Care, Clinical Trials, Medical Services, Oncology, Patient Support, Stem Cell Transplants

Symbol: TOI

Recent Price: $0.32

Industry: Medical - Care Facilities

CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.

Sector: Healthcare

Employees: 800

Address: 18000 Studebaker Road, Cerritos, CA 90703

Phone: 213 760 1328

Last updated: 2024-12-31